Citation: | XU Jin-xiu, ZHANG Jun-xia, XIANG Guang-da, ZHANG Bi-lin, LIN Xue. Correlation between CTRP3 and serum uric acid levels in patients with newly diagnosed type 2 diabetes[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2020, 24(4): 394-398. doi: 10.16462/j.cnki.zhjbkz.2020.04.005 |
[1] |
Li C, Hsieh MC. Metabolic syndrome, diabetes, and hyperuricemia[J]. Curr Opin Rheumatol, 2013, 25(2): 210-216. DOI: 10.1097/BOR.0b013e32835d951e.
|
[2] |
高尿酸血症相关疾病诊疗多学科共识专家组.中国高尿酸血症相关疾病诊疗多学科专家共识[J].中华内科杂志, 2017, 56(3): 235-248. DOI: 10.3760/cma.j.issn.0578-1426.2017.03.021.
Multidisciplinary consensus expert group for the diagnosis and treatment of hyperuricemia related diseases. Chinese multi-disciplinary consensus on the diagnosis and treatment of hyperuricemia and its related diseases[J]. Chin J Inter Med, 2017, 56(3): 235-248. DOI: 10.3760/cma.j.issn.0578-1426.2017.03.021.
|
[3] |
刘琰, 宋菲, 伍思佳, 等.内蒙古乌海市成人超重肥胖和甜饮料摄入对血尿酸的影响[J].中华疾病控制杂志, 2017, 21(3): 228-232. DOI: 10.16462/j.cnki.zhjbkz.2017.03.004.
Liu Y, Song F, Wu SJ, et al. The effects of overweight, obesity and sugar-sweetened beverage consumption on serum uric acid in adult residents of Wuhai, Inner Mongolian[J]. Chin J Dis Control Prev, 2017, 21(3): 228-232. DOI: 10.16462/j.cnki.zhjbkz.2017.03.004.
|
[4] |
Ali N, Perveen R, Rahman S, et al. Prevalence of hyperuricemia and the relationship between serum uric acid and obesity: a study on Bangladeshi adults[J]. PLoS One, 2018, 13(11): e0206850. DOI: 10.1371/journal.pone.0206850.
|
[5] |
Wang J, Chen RP, Lei L, et al. Prevalence and determinants of hyperuricemia in type 2 diabetes mellitus patients with central obesity in Guangdong province in China[J]. Asia Pac J Clin Nutr, 2013, 22(4): 590-598. DOI: 10.6133/apjcn.2013.22.4.16.
|
[6] |
张城林, 吴立玲, 李丽.补体C1q/肿瘤坏死因子相关蛋白3的研究进展[J].生理学报, 2017, 69(5): 666-676. DOI: 10.13294/j.aps.2017.0032.
Zhang CL, Wu LL, Li L. Research progress of complement-C1q/tumor necrosis factor-related protein 3[J]. Acta physiol Sin, 2017, 69(5): 666-676. DOI: 10.13294/j.aps.2017.0032.
|
[7] |
Moradi N, Fadaei R, Khamseh ME, et al. Serum levels of CTRP3 in diabetic nephropathy and its relationship with insulin resistance and kidney function[J]. PLoS One, 2019, 14(4): e0215617. DOI: 10.1371/journal.pone.0215617.
|
[8] |
Wolf RM, Steele KE, Peterson LA, et al. Lower circulating C1q/TNF-related protein-3(CTRP3)levels are associated with obesity: a cross-sectional study[J]. PLoS One, 2015, 10(7): e0133955. DOI: 10.1371/journal.pone.0133955.
|
[9] |
Qu H, Deng M, Wang H, et al. Plasma CTRP-3 concentrations in Chinese patients with obesity and type II diabetes negatively correlate with insulin resistance[J]. J Clin Lipidol, 2015, 9(3): 289-294. DOI: 10.1016/j.jacl.2015.03.006.
|
[10] |
Maltais-Payette I, Boulet MM, Prehn C, et al. Circulating glutamate concentration as a biomarker of visceral obesity and associated metabolic alterations[J]. Nutr Metab(Lond), 2018, 15: 78. DOI: 10.1186/s12986-018-0316-5.
|
[11] |
Yamada A, Sato KK, Kinuhata S, et al. Both visceral fat and liver fat are independently associated with hyperuricemia: the ohtori study[J]. Arthritis Care Res(Hoboken), 2016, 68(4): 553-561. DOI: 10.1002/acr.22729.
|
[12] |
Schmid A, Kopp A, Hanses F, et al. The novel adipokine C1q/TNF-related protein-3 is expressed in human adipocytes and regulated by metabolic and infection-related parameters[J]. Exp Clin Endocrinol Diabetes, 2012, 120(10): 611-617. DOI: 10.1055/s-0032-1323803.
|
[13] |
Hasegawa N, Fujie S, Horii N, et al. Aerobic exercise training-induced changes in serum C1q/TNF-related protein levels are associated with reduced arterial stiffness in middle-aged and older adults[J]. Am J Physiol Regul Integr Comp Physiol, 2018, 314(1): 94-101. DOI: 10.1152/ajpregu.00212.2017.
|
[14] |
Tsushima Y, Nishizawa H, Tochino Y, et al. Uric acid secretion from adipose tissue and its increase in obesity[J]. J Biol Chem, 2013, 288(38): 27138-27149. DOI: 10.1074/jbc.M113.485094.
|
[15] |
程杨阳, 张军霞. Clq-肿瘤坏死因子相关蛋白3与胰岛素抵抗相关性疾病的研究进展[J].中国糖尿病杂志, 2018, 26(2): 170-172. DOI: 10.3969/j.issn.1006-6187.2018.02.017.
Chen YY, Zhang JX. Research progressin Clq/TNF-related protein-3 and insulin resistance-related diseases[J]. Chin J Diabetes, 2018, 26(2): 170-172. DOI: 10.3969/j.issn.1006-6187.2018.02.017.
|
[16] |
Zhang J, Zhang B, Cheng Y. Low serum CTRP3 levels are associated with nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus[J]. Cytokine, 2018, 106: 131-135. DOI: 10.1016/j.cyto.2017.10.023.
|
[17] |
Li X, Jiang L, Yang M, et al. CTRP3 improves the insulin sensitivity of 3T3-L1 adipocytes by inhibiting inflammation and ameliorating insulin signalling transduction[J]. Endokrynol Pol, 2014, 65(4): 252-258. DOI: 10.5603/EP.2014.0034.
|
[18] |
Peterson JM, Wei Z. C1q/TNF-related protein-3(CTRP3), a novel adipokine that regulates hepatic glucose output[J]. J Biol Chem, 2010, 285(51): 39691-39701. DOI: 10.1074/jbc.M110.180695.
|
[19] |
Toyoki D, Shibata S, Kuribayashi-Okuma E, et al. Insulin stimulates uric acid reabsorption via regulating urate transporter 1 and ATP-binding cassette subfamily G member 2[J]. Am J Physiol Renal Physiol, 2017, 313(3): 826-834. DOI: 10.1152/ajprenal.00012.2017.
|